← Back to headlines
Novo Nordisk and Eli Lilly Sanctioned Over Obesity Drug Advertising
Pharmaceutical companies Novo Nordisk and Eli Lilly have been fined hundreds of thousands of euros for failing to comply with advertising restrictions for prescription-only anti-obesity medications.
Sources
Showing 0 of 1 sources
No articles available in your preferred languages.
1 article available in other languages below.
